CMS advises QInstruments shareholders on sale to BICO Group

Frankfurt/Main – The shareholders of QInstruments GmbH have sold their entire holding to Nasdaq Stockholm-listed BICO Group AB, formerly Cellink. QInstruments is headquartered in Jena, Germany. The company describes itself as a leading developer, manufacturer and supplier of solutions for sample preparation automation via mixing by liquid handling robots and workflows for biomedical and life science research and clinical diagnostics. QInstruments will continue to be managed as an independent company, forming part of BICO’s Bioautomation division. The purchase price is around EUR 61.25 million, of which EUR 3 million will be paid upon achievement of predetermined milestones.

A CMS team headed by lead partner Dr Joachim Dietrich and lead counsel Dr Dirk Baukholt advised the QInstruments shareholders on all legal aspects of the transaction.

CMS Germany

Dr Joachim Dietrich, Lead Partner, Frankfurt/Main
Dr Dirk Baukholt, Lead Counsel, Frankfurt/Main, both Corporate/M&A
Dr Boris Alles, Counsel, Frankfurt/Main, Labor, Employment & Pensions
Jörg Schrade, Partner, Munich, Tax

Press Contact
presse@cms-hs.com